Lipid-lowering effect and oral transport characteristics study of curculigoside
Frontiers in Cardiovascular Medicine · 02.07.2024 · 11
DOI: 10.3389/fcvm.2024.1426379 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 02.07.2024. Verfasst von Aiping Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shaoxing Maternity and Child Health Care Hospital, Shaoxing, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The incidence of metabolic disorders during pregnancy is increasing year by year, with diseases including hypertension and hyperlipidemia. Statins are the primary drugs for treating hyperlipidemia or atherosclerosis, yet some patients remain unresponsive to them, and pregnant women are prohibited from taking statins. Curculigoside is the major biologically active natural product present in Curculigo orchioides .
Methods
In this study, A high-fat mice model was developed to study the lipid-lowering effect of curculigoside. Using intestinal Caco-2 cell monolayer, the curculigoside transport properties at two temperatures and possible transporters were systemically studied.
Results
Curculigoside at concentrations used during the experiments have no toxic effect to Caco-2 cells. The curculigoside transfer from the apical to the basolateral side was strongly influenced by temperature. P-glycoprotein, breast cancer resistance protein, and efflux transporters are crucial components of the human intestinal cell line Caco-2. The curculigoside can significantly affect the contents of total cholesterol, triglycerides, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol in mice.
Discussion
The transport properties and potential mechanism of curculigoside offer valuable insights for the design of development of hypolipidemic drugs like anti-atherosclerotic drugs and also be helpful to the further study of the pharmacological activity of curculigoside.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shaoxing Maternity and Child Health Care Hospital, Shaoxing, China.
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China.
Zitieren
APA
Wang, A., Ning, J., Zhao, L., & Xu, R. (2024). Lipid-lowering effect and oral transport characteristics study of curculigoside. Frontiers in Cardiovascular Medicine, 11. https://doi.org/10.3389/fcvm.2024.1426379
Vancouver
Wang A, Ning J, Zhao L, Xu R. Lipid-lowering effect and oral transport characteristics study of curculigoside. Frontiers in Cardiovascular Medicine. 2024;11. doi:10.3389/fcvm.2024.1426379
BibTeX
@article{Wang2024,
author = {Wang, Aiping and Ning, Jie and Zhao, Lu and Xu, Renjie},
title = {Lipid-lowering effect and oral transport characteristics study of curculigoside},
journal = {Frontiers in Cardiovascular Medicine},
year = {2024},
volume = {11},
doi = {10.3389/fcvm.2024.1426379}
}
EUVIMED